[go: up one dir, main page]

DK2822568T3 - Anvendelser af caseinsammensætninger - Google Patents

Anvendelser af caseinsammensætninger Download PDF

Info

Publication number
DK2822568T3
DK2822568T3 DK13757439.8T DK13757439T DK2822568T3 DK 2822568 T3 DK2822568 T3 DK 2822568T3 DK 13757439 T DK13757439 T DK 13757439T DK 2822568 T3 DK2822568 T3 DK 2822568T3
Authority
DK
Denmark
Prior art keywords
case compositions
compositions
case
Prior art date
Application number
DK13757439.8T
Other languages
English (en)
Inventor
Aaron Calvin Fanning
Hasmukh Ambalal Patel
Johannes Schalk
Ramon Stafford Hall
Roger Richard Schwarzenbach
Sergey Yevgenievich Ukraintsev
Original Assignee
Fonterra Co-Operative Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49117099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2822568(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fonterra Co-Operative Group Ltd filed Critical Fonterra Co-Operative Group Ltd
Application granted granted Critical
Publication of DK2822568T3 publication Critical patent/DK2822568T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202Casein or caseinates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • A23L2/66Proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Water Supply & Treatment (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
DK13757439.8T 2012-03-09 2013-03-11 Anvendelser af caseinsammensætninger DK2822568T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261608858P 2012-03-09 2012-03-09
PCT/NZ2013/000035 WO2013133727A1 (en) 2012-03-09 2013-03-11 Uses of casein compositions

Publications (1)

Publication Number Publication Date
DK2822568T3 true DK2822568T3 (da) 2020-08-10

Family

ID=49117099

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13757439.8T DK2822568T3 (da) 2012-03-09 2013-03-11 Anvendelser af caseinsammensætninger

Country Status (14)

Country Link
US (3) US20150011468A1 (da)
EP (1) EP2822568B1 (da)
JP (1) JP6420156B2 (da)
CN (1) CN104159592B (da)
AU (1) AU2013202942B2 (da)
DK (1) DK2822568T3 (da)
ES (1) ES2811759T3 (da)
HK (1) HK1205947A1 (da)
HR (1) HRP20201197T1 (da)
HU (1) HUE050010T2 (da)
LT (1) LT2822568T (da)
NZ (1) NZ700686A (da)
PL (1) PL2822568T3 (da)
WO (1) WO2013133727A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201601999UA (en) 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for prevention and treatment of diabetes and obesity, and methods of production and use thereof in glucose and caloric control
US20170347680A1 (en) * 2014-12-26 2017-12-07 Compagnie Gervais Danone Process for making a viscous composition comprising whey protein
MY190600A (en) * 2015-05-22 2022-04-27 A2 Milk Co Ltd Beta-casein a2 and antioxidant capacity
TWI761487B (zh) * 2017-04-06 2022-04-21 日商明治股份有限公司 用於促進血中胺基酸濃度上升之發酵乳
MX2020004192A (es) 2017-10-30 2020-08-03 Frieslandcampina Nederland Bv Composiciones nutricionales densas en proteinas para su uso en el tratamiento y/o la prevencion de una afeccion relacionada con la perdida de masa y/o fuerza muscular.
JP7292012B2 (ja) 2018-06-14 2023-06-16 株式会社クボタ コンバイン
WO2020236772A1 (en) * 2019-05-20 2020-11-26 Rummel Iii Kirk Enhanced coffee or tea
WO2021210539A1 (ja) * 2020-04-13 2021-10-21 合同酒精株式会社 発酵乳及びその製造方法、並びに脱リン酸乳
US20210352938A1 (en) * 2020-05-12 2021-11-18 Raymond L. Sullivan, JR. Novel drink
JP7282061B2 (ja) 2020-06-25 2023-05-26 株式会社クボタ コンバイン
US20220030923A1 (en) * 2020-07-17 2022-02-03 Northern Innovations Holding Corp. Caffeine and Alpha Lipoic Acid Compositions for Enhanced Sensory Effects
CN114304369A (zh) * 2020-09-29 2022-04-12 内蒙古伊利实业集团股份有限公司 一种乳清蛋白组合物及其制备方法和应用
US20220225640A1 (en) * 2021-01-19 2022-07-21 Alexia Ramos Multipurpose Beverage Composition
WO2022225770A1 (en) * 2021-04-19 2022-10-27 Abbott Laboratories High protein liquid nutritional compositions
CN116210914A (zh) * 2023-03-02 2023-06-06 中国农业大学 一种胶束酪蛋白-花色苷复合物粉体组合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501675A (en) * 1999-12-09 2002-12-20 New Zealand Dairy Board Translucent milk drink having a pH of 5.7 to 7.0 and a percentage transmission of at least 5% prepared by a cation exchange process
NZ501676A (en) * 1999-12-09 2002-12-20 New Zealand Dairy Board Calcium-depleted milk protein products and use in cheese manufacture to reduce nugget-formation
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US20060159804A1 (en) * 2002-12-24 2006-07-20 Bhaskar Ganugapati V Dairy protein process and applications thereof
WO2010126353A1 (en) * 2009-04-27 2010-11-04 N.V. Nutricia Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
US20110256297A1 (en) * 2010-01-29 2011-10-20 Johns Paul W Nutritional Emulsions Comprising Calcium HMB and Soluble Protein
EP2592938B2 (en) * 2010-07-16 2024-12-04 Fonterra Co-Operative Group Ltd Dairy product and process

Also Published As

Publication number Publication date
CN104159592B (zh) 2018-10-19
HK1205947A1 (en) 2015-12-31
ES2811759T3 (es) 2021-03-15
EP2822568A1 (en) 2015-01-14
CN104159592A (zh) 2014-11-19
AU2013202942B2 (en) 2016-05-12
EP2822568B1 (en) 2020-06-17
JP6420156B2 (ja) 2018-11-07
EP2822568A4 (en) 2015-11-11
HUE050010T2 (hu) 2020-11-30
US20190105371A1 (en) 2019-04-11
AU2013202942A1 (en) 2013-09-26
HRP20201197T1 (hr) 2020-11-13
JP2015509531A (ja) 2015-03-30
WO2013133727A1 (en) 2013-09-12
PL2822568T3 (pl) 2020-11-16
US20170232063A1 (en) 2017-08-17
US20150011468A1 (en) 2015-01-08
LT2822568T (lt) 2020-09-10
NZ700686A (en) 2016-08-26

Similar Documents

Publication Publication Date Title
SMT201700094B (it) Composto di pirazina carbossammide
DK2822568T3 (da) Anvendelser af caseinsammensætninger
DK3725778T3 (da) Formuleringer af enzalutamid
LT2791160T (lt) Modifikuotos mrnr sudėtys
DK2911506T3 (da) Driftreducerende sammensætninger
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK3156056T3 (da) Farmaceutiske sammensætninger der består af sorbitanestere
DK3450434T3 (da) Deutererede derivater af ruxolitinib
DK3336097T3 (da) Fremstilling af ikke-krystallinsk obeticholsyre
BR112013017183A2 (pt) composições de bepostatina
BR112015002651A2 (pt) composições cosméticas
EP2912131A4 (en) Adhesive compositions
BR112014032798A2 (pt) composição
DK3461895T3 (da) Modulation af ube3a-ats-ekspression
EP2900621A4 (en) BIOKERAMIKZUSAMMENSETZUNGEN
BR112015003038A2 (pt) composições lubrificantes
CO6930368A2 (es) Composiciones de yodo-povidona estable
ME03413B (me) Kompozicije које sadrže peg i askorbat
DK3106150T3 (da) Forbedrede farmaceutiske sammensætninger af pimobendan
EP2807289A4 (en) ETCHING COMPOSITION
BR112015001562A2 (pt) biotinas e composições
DK2822967T3 (da) Compositions comprising secretory - like immunoglobulins
DK2800572T3 (da) Sammensætning af ellagitannin-rige ekstrakter
DK2919777T3 (da) Transmukosal afgivelse af tocotrienol
DK2925338T3 (da) Frysetørret formulering af tat-nr2b9c